Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 17

1.

Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch.

Lepage M, Dow WC, Melchior M, You Y, Fingleton B, Quarles CC, P├ępin C, Gore JC, Matrisian LM, McIntyre JO.

Mol Imaging. 2007 Nov-Dec;6(6):393-403.

PMID:
18053410
2.

Cysteine cathepsins: cellular roadmap to different functions.

Brix K, Dunkhorst A, Mayer K, Jordans S.

Biochimie. 2008 Feb;90(2):194-207. Epub 2007 Aug 6. Review.

PMID:
17825974
3.

Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition.

Preda A, van Vliet M, Krestin GP, Brasch RC, van Dijke CF.

Invest Radiol. 2006 Mar;41(3):325-31. Review.

PMID:
16481916
4.

Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.

Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y.

Exp Biol Med (Maywood). 2006 Jan;231(1):20-7. Review.

PMID:
16380641
5.

Lysosomal cysteine proteases in atherosclerosis.

Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1359-66. Epub 2004 Jun 3. Review.

6.

Role of matrix metalloproteinases (MMPs) in colorectal cancer.

Zucker S, Vacirca J.

Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):101-17. Review.

PMID:
15000152
7.

Functional structure and composition of the extracellular matrix.

Bosman FT, Stamenkovic I.

J Pathol. 2003 Jul;200(4):423-8. Review.

PMID:
12845610
8.

MT1-MMP and MMP-7 in invasion and metastasis of human cancers.

Shiomi T, Okada Y.

Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):145-52. Review.

PMID:
12784993
9.

Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis.

Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E.

Oncogene. 2002 Aug 29;21(38):5951-5.

10.

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Wang YX, Hussain SM, Krestin GP.

Eur Radiol. 2001;11(11):2319-31. Review.

PMID:
11702180
11.

Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.

Gossmann A, Okuhata Y, Shames DM, Helbich TH, Roberts TP, Wendland MF, Huber S, Brasch RC.

Radiology. 1999 Oct;213(1):265-72.

PMID:
10540670
12.

Tumor progression and angiogenesis: cathepsin B & Co.

Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, Sloane BF.

Biochem Cell Biol. 1996;74(6):799-810. Review.

PMID:
9164649
13.
14.

Molecular and cellular basis of cancer invasion and metastasis: implications for treatment.

Jiang WG, Puntis MC, Hallett MB.

Br J Surg. 1994 Nov;81(11):1576-90. Review.

PMID:
7827878
15.

Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies.

Schmiedl U, Ogan M, Paajanen H, Marotti M, Crooks LE, Brito AC, Brasch RC.

Radiology. 1987 Jan;162(1 Pt 1):205-10.

PMID:
3786763
16.

Future directions in magnetic resonance contrast media.

Runge VM, Gelblum DY.

Top Magn Reson Imaging. 1991 Mar;3(2):85-97. Review.

PMID:
2025435
17.

New directions in the development of MR imaging contrast media.

Brasch RC.

Radiology. 1992 Apr;183(1):1-11. Review.

PMID:
1549653

Supplemental Content

Support Center